A bridging study of fananserin in schizophrenic patients

Psychopharmacology Bulletin

Volumn 34, Issue 4, 1998, Pages 811-818

  Sramek, J J ^a   Kirkesseli, S ^a   Paccaly Moulin, A ^a   Davidson, J ^a   Jhee, S S ^a   Hourani, J ^a   Semiond, D ^a   Cutler, N R ^a  

^a NONE   (United States)

Author keywords

Atypical antipsychotics; Bridging studies; Dopamine D4 receptors; Fananserin; Schizophrenia

Indexed keywords

DOCUSATE SODIUM; FANANSERIN; MYLANTA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; FEVER; HEADACHE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHIZOPHRENIA; VERTIGO;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; CYCLIC S-OXIDES; FEMALE; HUMANS; MALE; MIDDLE AGED; NAPHTHALENES; SCHIZOPHRENIA;

EID: 0032287264     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)